Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2017

Mar 14, 2017

29875_dirs_2017-03-14_20b306d8-530b-4330-b097-d0b63ba70eef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-03-13

Reporting Person: Sussman Andrew (EVP, Clinical Services)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-13 Common Stock M 6655 $45.07 Acquired 22801 Direct
2017-03-13 Common Stock S 6655 $80.40 Disposed 16146 Direct
2017-03-13 Common Stock S 7449 $80.40 Disposed 8697 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-13 Stock Option $45.07 M 6655 Disposed 2019-04-02 Common Stock (6655) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 17313 Direct
Stock Unit 10144.5863 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $54.53 2020-04-01 Common Stock (11802) 11802 Direct
Stock Option $74.29 2021-04-01 Common Stock (29373) 29373 Direct
Stock Option $102.26 2022-04-01 Common Stock (23968) 23968 Direct
Stock Option $104.82 2023-04-01 Common Stock (23301) 23301 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Option became exercisable in four equal annual installments, commencing 4/2/2013.

F3: Option became exercisable in four equal annual installments, commencing 4/1/2014.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F6: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.